Technicals

Will Mosaic (MOS) Gain on Rising Earnings Estimates?

Mosaic (MOS) appears an attractive pick given a noticeable improvement in the company’s earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company. The upward trend in estimate revisions for this fertilizer maker reflects growing optimism of analysts on its earnings prospects, which should get reflected in its stock price […]

Technicals

Why Magic Software (MGIC) Might be Well Poised for a Surge

Magic Software (MGIC) could be a solid addition to your portfolio given a notable revision in the company’s earnings estimates. While the stock has been gaining lately, the trend might continue since its earnings outlook is still improving. The upward trend in estimate revisions for this business process integration software company reflects growing optimism of analysts on its earnings prospects, which should get reflected in its stock price. […]

Technicals

Kroger (KR) Earnings Expected to Grow: Should You Buy?

Kroger (KR) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended July 2020. This widely-known consensus outlook gives a good sense of the company’s earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. […]

Technicals

3 Reasons Growth Investors Will Love Federated Hermes (FHI)

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market’s attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task. In addition to volatility, these stocks carry above-average risk by their very nature […]

Stock Analysts

Horizon Therapeutics’ Stock Rises YTD on Approvals & Buyouts

Shares of Horizon Therapeutics Public Limited Company HZNP have surged 99.4% year to date against the industry ’s decline of 1.5%. The year has been good for the company with several positive regulatory and pipeline developments.Some factors that have led to the growth are as follows. In January 2020, the FDA approved the company’sdrug, Tepezza, for the treatment ofpatients with thyroid eye disease (TED) […]

Stock Analysts

Gilead-HiFiBiO Ink Deal to Develop Antibodies Against Leukemia

Gilead Sciences, Inc.’s GILD subsidiary, Kite, entered into a two-year research collaboration and license agreement with HiFiBiO Therapeutics to develop antibodies and novel targets against acute myeloid leukemia (AML). Per the deal, HiFiBiO Therapeutics will develop the novel AML targets and anti-AML specific antibodies leveraging its proprietary single-cell platform, which will be used by Kite in its cell therapies. HiFiBiO will receive an undisclosed upfront payment and be eligible for additional payments based on the completion of some research activities on the candidates […]

Stock Analysts

Chevron Postpones Scheduled Restart of Train 2 Until October

Chevron Corporation CVX recently announced that it will push back the expected restart date of Train 2 at its Gorgon liquefied natural gas plant in Western Australia until October. The reason for this delay is that the company requires additional time to fix and restore welds on its propane heat exchangers. Since May 2020, Train 2 at Australia's second-largest LNG plant has been shut for maintenance purpose […]

Stock Analysts

7 Reasons That Make Halliburton (HAL) Investor Favorite Now

Even if a stock shows an impressive run on the bourse, some investors feel jittery about adding it to their portfolios, thinking there is not much upside potential left. While this is true in certain cases, a high-flying company may still consider the stock to be a meatier option for bargain right now. In case of oilfield service company Halliburton Company HAL , there are seven good reasons to place it as an attractive bet, more so when it is already on an upswing […]

Stock Analysts

Gladstone Acquires Industrial Asset, Grows Indiana Portfolio

Gladstone Commercial Corporation GOOD recently announced the completion of acquisition of an industrial property in Terre Haute IN, for $10.6 million. The strategic move is in sync with the company’s efforts to fortify its portfolio of high-quality assets in the thriving markets with creditworthy tenants. The 153,600-square-foot distribution building, constructed as a build-to-suit in 2010, is fully leased to Clabber Girl Corporation with full guaranty from its publicly traded parent company B&G Foods BGS . […]